BR112017012665A2 - método para produzir um sistema de dispensação farmacêutica, uso de um carbonato de cálcio, e, sistema de dispensação farmacêutica. - Google Patents

método para produzir um sistema de dispensação farmacêutica, uso de um carbonato de cálcio, e, sistema de dispensação farmacêutica.

Info

Publication number
BR112017012665A2
BR112017012665A2 BR112017012665A BR112017012665A BR112017012665A2 BR 112017012665 A2 BR112017012665 A2 BR 112017012665A2 BR 112017012665 A BR112017012665 A BR 112017012665A BR 112017012665 A BR112017012665 A BR 112017012665A BR 112017012665 A2 BR112017012665 A2 BR 112017012665A2
Authority
BR
Brazil
Prior art keywords
dispensing system
pharmaceutical dispensing
producing
calcium carbonate
pharmaceutical
Prior art date
Application number
BR112017012665A
Other languages
English (en)
Inventor
Huwyler Jörg
Puchkov Maxim
Atria Susanna
Stirnimann Tanja
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of BR112017012665A2 publication Critical patent/BR112017012665A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

a presente invenção se refere a um método para produzir um sistema de dispensação farmacêutica, ao uso de um carbonato de cálcio reagido na superfície para melhorar a friabilidade de um sistema de dispensação farmacêutica assim como para melhorar a fluxibilidade de um sistema de dispensação farmacêutica e um sistema de dispensação farmacêutica obtido pelo método.
BR112017012665A 2014-12-18 2015-12-16 método para produzir um sistema de dispensação farmacêutica, uso de um carbonato de cálcio, e, sistema de dispensação farmacêutica. BR112017012665A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP14199037.4A EP3034070A1 (en) 2014-12-18 2014-12-18 Method for the production of a pharmaceutical delivery system
US201462095865P 2014-12-23 2014-12-23
US201562232516P 2015-09-25 2015-09-25
PCT/EP2015/080016 WO2016096997A1 (en) 2014-12-18 2015-12-16 Method for the production of a pharmaceutical delivery system

Publications (1)

Publication Number Publication Date
BR112017012665A2 true BR112017012665A2 (pt) 2017-12-26

Family

ID=52338877

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017012665A BR112017012665A2 (pt) 2014-12-18 2015-12-16 método para produzir um sistema de dispensação farmacêutica, uso de um carbonato de cálcio, e, sistema de dispensação farmacêutica.

Country Status (18)

Country Link
US (1) US20190022012A1 (pt)
EP (2) EP3034070A1 (pt)
JP (1) JP2017538733A (pt)
KR (1) KR20170098894A (pt)
CN (1) CN107106498A (pt)
AR (1) AR103077A1 (pt)
AU (1) AU2015367524B2 (pt)
BR (1) BR112017012665A2 (pt)
CA (1) CA2969763A1 (pt)
CO (1) CO2017005500A2 (pt)
CR (1) CR20170236A (pt)
MX (1) MX2017007880A (pt)
PH (1) PH12017501035A1 (pt)
RU (1) RU2693491C2 (pt)
SG (1) SG11201704513VA (pt)
TW (1) TW201627009A (pt)
UY (1) UY36444A (pt)
WO (1) WO2016096997A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3260115A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
BR112021025200A2 (pt) 2019-06-17 2022-02-01 Dsm Ip Assets Bv Composição compreendendo metformina hcl, vitamina b12 e pelo menos um aditivo de fluxo
US20210059932A1 (en) * 2019-08-28 2021-03-04 Vincent Langlois Multi-layer edible strip containing active medicinal ingredients
CN111419815B (zh) * 2020-04-23 2022-03-11 永信药品工业（昆山）股份有限公司 依托考昔片及其优化方法
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
EP3928859A1 (en) 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
CN113413388B (zh) * 2021-06-30 2022-11-15 上海奥全生物医药科技有限公司 含有枸橼酸西地那非的药物组合物、制备方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (pt) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
PL149493B1 (en) 1985-04-12 1990-02-28 Method of obtaining a tablet capable to buoy over surface of gastric juice
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
WO1995005809A1 (fr) 1993-08-20 1995-03-02 Nippon Shinyaku Co., Ltd. Preparation restant dans l'estomac, forme moulee gonflee, et procede de preparation
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
CA2420461C (en) * 2000-09-06 2008-08-12 Tanabe Seiyaku Co., Ltd. Preparations for oral administration
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
DE602007009124D1 (de) 2007-12-12 2010-10-21 Omya Development Ag Verfahren zur Herstellung von oberflächenreaktives Fällungskalziumkarbonat
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
DK2264108T3 (da) 2009-06-15 2012-05-29 Omya Development Ag Fremgangsmåde til fremstilling af et calciumcarbonat, der har reageret på overfladen, under anvendelse af en svag syre
ATE542862T1 (de) 2009-06-15 2012-02-15 Omya Development Ag Verfahren zur herstellung von oberflächenreaktivem kalziumkarbonat und verwendung
SI2679638T1 (sl) 2012-06-28 2015-11-30 Omya International Ag Vodna mineralna in/ali polnilna in/ali pigmentna suspenzija z visoko vrednostjo trdnih delcev v kislinskem ph okolju
EP2719373B1 (en) * 2012-10-12 2017-04-19 Omya International AG Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
EP2810656B1 (en) * 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
RU2646113C1 (ru) * 2016-09-06 2018-03-01 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ получения системы доставки фрагментов нуклеиновых кислот в клетки млекопитающих

Also Published As

Publication number Publication date
CR20170236A (es) 2017-09-26
RU2693491C2 (ru) 2019-07-03
RU2017125320A (ru) 2019-01-18
AR103077A1 (es) 2017-04-12
TW201627009A (zh) 2016-08-01
CO2017005500A2 (es) 2017-09-29
AU2015367524B2 (en) 2018-03-15
CA2969763A1 (en) 2016-06-23
MX2017007880A (es) 2017-09-05
UY36444A (es) 2016-04-29
WO2016096997A1 (en) 2016-06-23
US20190022012A1 (en) 2019-01-24
AU2015367524A1 (en) 2017-07-20
SG11201704513VA (en) 2017-07-28
JP2017538733A (ja) 2017-12-28
KR20170098894A (ko) 2017-08-30
EP3034070A1 (en) 2016-06-22
CN107106498A (zh) 2017-08-29
EP3233062A1 (en) 2017-10-25
RU2017125320A3 (pt) 2019-01-18
PH12017501035A1 (en) 2018-03-05

Similar Documents

Publication Publication Date Title
BR112017012665A2 (pt) método para produzir um sistema de dispensação farmacêutica, uso de um carbonato de cálcio, e, sistema de dispensação farmacêutica.
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
BR112018073384A2 (pt) polinucleotídeos moduladores
EP4282983A3 (en) Compositions and methods for polynucleotide sequencing
BR112016024644A2 (pt) vacinas de ácido nucleico
MX371188B (es) Proceso para preparar un eritritol directamente comprimible y usos de este.
BR112016018654A2 (pt) Composições de silicato estabilizadas e seu uso como composições antiperspirantes
BR112018000187A2 (pt) composto, composição, método, e, uso de um composto ou composição
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CL2016000038A1 (es) Piraxolo-piridinaminas sustituidas
UY35986A (es) Método mejorado para la producción de extractos de ginkgo
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
MX2019010367A (es) Formulacion acuosa de anticuerpo anti ligando 1 de muerte programada (pd-l1).
BR112017001391A2 (pt) componentes para o fusionamento de corpos vertebrais
IN2014MU00455A (pt)
BR112017008854A2 (pt) partículas de cadotrila
PL3166978T3 (pl) Sposób wytwarzania stabilnych względem zamrażania i rozmrażania dyspersji wodnych
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
EA201691924A1 (ru) Фармацевтические композиции
IN2014CH00304A (pt)
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
AR103779A1 (es) Proceso para la producción de carbonato de calcio precipitado de alto contenido de sólidos con aditivo catiónico
BR112017012150A2 (pt) processo para preparação de carbonato de cálcio precipitado, carbonato de cálcio precipitado, e, uso de um carbonato de cálcio precipitado.
BR112017015728A2 (pt) método de produção de substância
MX2017004770A (es) Formas solidas del clorhidrato de nilotinib.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2649 DE 13-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.